MetaCap

Canton Strategic Holdings Inc. (CNTN)

NASDAQ: CNTNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.21-0.02 (-1.63%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CNTN stock chart

Technical analysis

Key statistics

All statistics
Market cap
$98.78M
52-week range
1.19 – 5.83
Day range
1.19 – 1.28
Volume / Avg
876.71K / 763.63K
Beta
—

52-week range

$1.19$5.83

CNTN stock today

On Nov 20, CNTN ended the session at $1.21, shedding $0.02 (1.63%), versus the S&P 500's 3.70% decline. Shares are 79.2% below their 52-week high of $5.83, set on Feb 2, 2026 and 1.7% above the 52-week low of $1.19, near the bottom of the past year's range. CNTN is down 60.1% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 50.6%.

Canton Strategic trades at 20.2x its trailing twelve-month earnings per share of $0.06.

Summary generated from market data by MetaCap's automated system. Methodology

About Canton Strategic

Company profile

Canton Strategic Holdings, Inc. focuses on advancing institutional blockchain adoption and digitizing financial markets in the United States. The company operates as a validator and super validator on the Canton Network, which provides validation and liveness services to the network.

Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. Mark Wendland
Headquarters
New York, NY
Employees
12
IPO year
2022

Financial highlights

Full financials

Canton Strategic reported a net loss of $35.9 million, compared with a loss of $12.2 million a year earlier. Diluted earnings per share came in at -$1.12.

Canton Strategic annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue—————
Growth—————
Net income$-35.92M$-12.20M$-9.32M$-8.47M$-2.21M
EPS (diluted)$-1.12$-9.41$-107.02$-18.72$-0.35

Earnings

Earnings history
Last reported (Sep/2026)
Nov 16, 2026
EPS actual vs est.
$-0.18 vs —

CNTN news

All CNTN news

Canton Strategic peers

Health Care sector
CNTN peer companies
CompanyPrice% ChgMarket capCompare
ORGOOrganogenesis Holdings Inc. Class A0.7716-2.23%$100.16Mvs CNTN
NERVMinerva Neurosciences Inc2.00-5.66%$99.67Mvs CNTN
UNCYUnicycive Therapeutics Inc.3.35-5.10%$97.77Mvs CNTN
FHTXFoghorn Therapeutics Inc.1.72-3.37%$103.14Mvs CNTN
GNLXGenelux Corporation2.17-4.82%$103.36Mvs CNTN
NBPNovaBridge Biosciences ADR0.83-5.66%$96.28Mvs CNTN
PDSBPDS Biotechnology Corporation0.7774-3.70%$95.39Mvs CNTN
NRXPNRX Pharmaceuticals Inc.2.15-15.69%$95.31Mvs CNTN

Indexes, lists and sector

Canton Strategic stock FAQ

What is Canton Strategic's stock price today?

CNTN last traded at $1.21 as of Nov 20, 4:00 PM EST, down 1.63% on the day. Prices are delayed at least 15 minutes.

Does Canton Strategic pay a dividend?

No. Canton Strategic does not currently pay a regular cash dividend.

What is CNTN's P/E ratio?

CNTN trades at a trailing P/E ratio of 20.17.

Who is Canton Strategic's CEO?

Mr. Mark Wendland is the chief executive officer of Canton Strategic Holdings Inc., which has about 12 employees.

Has CNTN ever split its stock?

Yes. The most recent CNTN stock split was a 1-for-15 split on May 28, 2024, one of 2 splits on record.

What is the CNTN 52-week high?

The 52-week high for CNTN is $5.83 and the 52-week low is $1.19. The stock is currently 79.2% below its high.

Compare CNTN